Related Experiment Video
Updated: May 15, 2026

Developing a Rat Model for Bipolar Disorder
Published on: May 2, 2025
Mood instability and functional recovery in bipolar disorders
S A Strejilevich1, D J Martino, A Murru
1Bipolar Disorder Program, Neuroscience Institute, Favaloro University, Buenos Aires, Argentina. sstrejilevich@ffavaloro.org
Objective:
The aim of this study was to identify psychopathological factors associated with long-term functional outcome in euthymic bipolar disorder patients and to test new measures of mood instability and symptoms intensity.
Method:
Fifty-five patients with more than 12 months of follow-up were included. In addition to traditional clinical variables, the time spent ill was documented using a modified life-charting technique based on NIHM life-charting method. New measures, Mood Instability Factor, and Mood Intensity Factor were defined and assessed. Functioning Assessment Short Test (FAST) was used to assess disability.
Results:
The follow-up period was 3.00 ± 1.51 years. Weeks with subsyndromal depressive symptoms (β = 0.133, t = 2.556, P = 0.014), weeks with mild manic symptoms (β = 1.441, t = 3.10, P = 0.003), and the Mood Instability Factor (β = 0.105, t = 3.593, P = 0.001) contributed to approximately 46% of the FAST total score variance.
Conclusion:
New methodologies including subsyndromal symptoms and mood instability parameters might contribute to understand the worse long-term functional outcome that affects a considerable percentage of BD patients even after episode remission. Concerns about therapeutic approaches are discussed.
Related Concept Videos
Bipolar Disorder
Mania and Antimanic Drugs: Overview
Borderline Personality Disorder
Genetic and Environmental Contributions
Borderline Personality...
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Psychosis: Goals of Pharmacotherapy
Depressive Disorders: MDD and Dysthymia